Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Capecitabine × Clear all

Sponsor

Conditions

Breast Neoplasms 103 Colorectal Neoplasms 65 Stomach Neoplasms 41 Pancreatic Neoplasms 39 Rectal Neoplasms 36 Neoplasm Metastasis 28 Neoplasms 26 Esophageal Neoplasms 16 Colonic Neoplasms 16 Triple Negative Breast Neoplasms 13 Adenocarcinoma 11 Gallbladder Neoplasms 9 Bile Duct Neoplasms 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Brain Neoplasms 7 Adenocarcinoma Of Esophagus 7 Liver Neoplasms 6 Cholangiocarcinoma 5 Squamous Cell Carcinoma of Head and Neck 4 Biliary Tract Neoplasms 4 Somatostatinoma 3 Gastrinoma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Breast Neoplasms, Male 3 Solid Tumor 2 Skin Neoplasms 2 Ovarian Neoplasms 2

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡